Design of drug-like hepsin inhibitors against prostate cancer and kidney stones
Hepsin, a transmembrane serine protease abundant in renal endothelial cells, is a promising therapeutic target against several cancers, particularly prostate cancer. It is involved in the release and polymerization of uromodulin in the urine, which plays a role in kidney stone formation. In this wor...
Saved in:
Main Authors: | Vincent Blay (Author), Mu-Chun Li (Author), Sunita P. Ho (Author), Mashall L. Stoller (Author), Hsing-Pang Hsieh (Author), Douglas R. Houston (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepsin immunohistochemical expression in prostate cancer in relation to Gleason's grade and serum prostate specific antigen
by: Madhu Mati Goel, et al.
Published: (2011) -
A High-Affinity <sup>64</sup>Cu-Labeled Ligand for PET Imaging of Hepsin: Design, Synthesis, and Characterization
by: Ji-Hun Park, et al.
Published: (2022) -
A Review on Kidney Stones & A Patient Satisfaction Survey of an Ayurvedic Brand to Treat Kidney Stones
by: Kishor Jain, et al.
Published: (2023) -
Proton pump inhibitors use is associated with a higher prevalence of kidney stones: NHANES 2007-2018
by: Youjie Zhang, et al.
Published: (2024) -
Metabolic disorders in kidney stone disease in children
by: Monika Kusz, et al.
Published: (2020)